Clinical Trial Update: Interferon Responses in Eczema Herpeticum

View source ↗

Summary

An NIAID-sponsored clinical trial investigating interferon responses in eczema herpeticum has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis
• Eczema Herpeticum
• Eczema Vaccinatum
• Herpes Simplex Infection

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Atopic Dermatitis, Eczema Herpeticum | Status: COMPLETED